Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Survival of Patients With Advanced Metastatic Melanoma: The Impact of MAP Kinase Pathway Inhibition and Immune Checkpoint Inhibition - Update 2019Eur. J. Cancer 2020 Mar 13;[EPub Ahead of Print], S Ugurel, J Röhmel, PA Ascierto, JC Becker, KT Flaherty, JJ Grob, A Hauschild, J Larkin, E Livingstone, GV Long, P Lorigan, GA McArthur, A Ribas, C Robert, L Zimmer, D Schadendorf, C Garbe
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.